Advertisement
Screener

BOUNDLESS BIO, INC. (BOLD) Price / Book

2.8 / 5 stars · 68/120 Roast Me

Boundless Bio, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

  • Boundless Bio, Inc. price/book ratio for the quarter ending 2026-06-30 was 0.85, a 351.87% increase year-over-year.
  • Boundless Bio, Inc. price/book ratio for the quarter ending 2026-03-31 was 0.29, a 17.32% increase year-over-year.
  • Boundless Bio, Inc. price/book ratio for the quarter ending 2025-12-31 was 0.27, a 37.04% decline year-over-year.
  • Boundless Bio, Inc. price/book ratio for the quarter ending 2025-09-30 was 0.25, a 46.79% decline year-over-year.
  • Boundless Bio, Inc. price/book ratio for fiscal 2026 was 0.85.
  • Boundless Bio, Inc. price/book ratio for fiscal 2025 was 0.27, a 37.04% decline from fiscal 2024.
  • Boundless Bio, Inc. price/book ratio for fiscal 2024 was 0.43.
Available history
2024-03-31 to 2026-06-30
Data captured

Historical Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-300.85$56.3M$65.98M
2026-03-310.29$24.98M$86.38M
2025-12-310.27$26.66M$98.65M
2025-09-300.25$27.42M$110.17M
2025-06-300.19$23.17M$122.69M
2025-03-310.25$33.67M$136.59M
2024-12-310.43$64.67M$150.64M
2024-09-300.47$77.22M$165.08M
2024-06-300.48$86.12M$179.25M
2024-03-31-0.13$17.99M-$141.18M

Annual Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-300.85$56.3M$65.98M
2025-12-310.27$26.66M$98.65M
2024-12-310.43$64.67M$150.64M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
TALPHERA, INC. (TLPH)United States$0.060B
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Clene Inc. (CLNN)United States$0.054B-1.99
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
HYPERION DEFI, INC. (HYPD)United States$0.065B